Varex Imaging offers a statistically high-asymmetry setup (4.46 ratio, 47.6% modeled upside) riding a strong earnings beat streak, but a death-cross hard block, a quality score below the engine's floor, and thinly covered analyst sentiment keep the setup speculative.
Thesis pillars
- High Asymmetry Earnings Catalyst Setup→Stable
- Quality Below Floor On Cash Burn→Stable
- Death Cross Hard Block Despite Recovery Signs→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 5, 2026, based on the 10-K filed Nov 18, 2025
Varex Imaging Corporation (VREX) Stock Analysis
Range Bound setup · Catalyst-Driven edge
Healthcare · Medical Devices
Sell if holding. Engine safety override at $18.45: Quality below floor (4.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Elevated put/call ratio: 3.00; Below-average business quality.
Varex Imaging designs and manufactures X-ray imaging components — X-ray tubes, flat panel and photon-counting detectors, linear accelerators, and imaging software — sold to OEM customers through its Medical and Industrial segments, with about 2,400 employees across North... Read more
Sell if holding. Engine safety override at $18.45: Quality below floor (4.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Elevated put/call ratio: 3.00; Below-average business quality. Chart setup: RSI 47 mid-range, Bollinger mid-band. Score 5.2/10, moderate confidence.
Passes 5/8 gates (no SEC red flags, news events none recent, earnings proximity 19d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and clean insider activity. Suitability: aggressive.
About Varex Imaging Corporation
About Varex Imaging Corporation
Varex Imaging's largest customer, Canon Medical Systems, accounted for 18% of fiscal 2025 revenue, while its ten largest customers together made up roughly 52%. The company employs approximately 2,400 people across manufacturing and engineering sites in North America, Europe, and Asia, split between Medical and Industrial segments that design, build, and service X-ray tubes, detectors, and imaging systems.
Varex sells X-ray tubes, flat panel and photon counting detectors, linear accelerators, and imaging software primarily to OEM customers that design the components into medical, security, and industrial inspection systems, then depends on replacement and service revenue as tubes and detectors wear out — CT tubes typically every 2 to 6 years, and as often as every 10 to 20 months in China given high equipment utilization. The company competes against in-house X-ray tube production at major diagnostic imaging companies such as Canon and Philips Healthcare, as well as against detector makers including Trixell, Vieworks, Hamamatsu, and iRay Technology. Manufacturing spans eight countries, including the United States, Germany, and the Philippines, with certain components — transistor arrays and cesium iodide coatings for digital detectors, and specialized X-ray tube targets among them — sourced from a limited group of suppliers or a single source. Revenue from customers outside the United States made up 70% of total fiscal 2025 revenue.
Show full overview
Varex's China exposure illustrates a risk distinct from customer concentration: medical X-ray tubes imported into China made up 10% of total revenue in fiscal 2025, and in April 2025 China's Ministry of Commerce opened MOFCOM investigations into US-origin CT X-ray tubes and tube inserts, before suspending both indefinitely in November 2025. Should the investigations resume and result in new tariffs, Varex has cautioned that its export prices to China may no longer compete with local manufacturers. The company also holds joint-venture stakes — including a 40% interest in dpiX, its amorphous-silicon detector-array supplier, and a 75% stake in Varex Imaging Arabia — that have drawn shareholder disputes and litigation in Germany since 2023.
See also: Healthcare · Medical Devices
From Varex Imaging Corporation's most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-10-29Recent Developments — Varex Imaging Corporation
Latest news
- NEWS Deal Dispatch: Safe Harbor Marinas Buys MarineMax, Thoma Bravo Acquires Accelerant, 777 Partners Bankruptcy — benzinga Aug 14, 2026 neutral
- NEWS This AppLovin Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday — benzinga Aug 11, 2026 neutral
- NEWS Oppenheimer Downgrades Varex Imaging to Perform — benzinga Aug 11, 2026 negative
- NEWS 12 Health Care Stocks Moving In Monday's Intraday Session — benzinga Aug 10, 2026 neutral
- NEWS Teledyne Snaps up Varex Imaging for $1.1 Billion — benzinga Aug 10, 2026 negative
Generated 2026-10-29T11:14:36Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Negative sentiment — recent news tone and/or analyst downgrades drag the composite below neutral.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $18.45: Quality below floor (4.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Elevated put/call ratio: 3.00; Below-average business quality. Chart setup: RSI 47 mid-range, Bollinger mid-band. Prior stop was $18.35. Score 5.2/10, moderate confidence.
Analyst target $16.06 reached (−12.9% from $18.45); no take-profit level is published. Prior stop was $18.35. Stop-loss: $18.35.
Target reached (-12.9% upside); Quality below floor (4.0 < 4.0); Value-trap signals (4/5): Margin compression (op margin -81.6%), High leverage (D/E 1.7), Material insider selling (4 sells, 0.03% of cap)….
Varex Imaging Corporation trades at a P/E of 34.8 (forward 17.2). TrendMatrix value score: 7.7/10. Verdict: Sell.
8 analysts cover VREX with a consensus score of 2.4/5. Average price target: $19.
What does Varex Imaging Corporation do?Varex Imaging designs and manufactures X-ray imaging components — X-ray tubes, flat panel and photon-counting...
Varex Imaging designs and manufactures X-ray imaging components — X-ray tubes, flat panel and photon-counting detectors, linear accelerators, and imaging software — sold to OEM customers through its Medical and Industrial segments, with about 2,400 employees across North America, Europe, and Asia. The company's largest customer, Canon Medical Systems, accounted for 18% of fiscal 2025 revenue, and its ten largest customers together made up roughly 52%. Long design-in relationships with OEMs, some spanning over 35 years, create switching costs that favor Varex's incumbency in replacement compone